Prolong Pharmaceuticals
A biotechnology company developing treatments for hematology and oncology diseases
1
Funding Rounds
$30.0m
Money raised
Overview
A biotechnology company developing treatments for hematology and oncology diseases
- Websites:
- Business model: B2B
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ni**** Pa*** | - | - | |
| Ch***** Ra*** | - | - | - |
Funding series
Funding Series Analysis
The company Prolong Pharmaceuticals has raised a total of $30m in funding over 1 rounds.
Key Insights:
- Prolong Pharmaceuticals funding round, October 2010: $30m
Prolong Pharmaceuticals funding round, October 2010
$30m
Industries
Prolong Pharmaceuticals is active in the following industries: